Home Tags Alzheimer’s Disease

Alzheimer’s Disease Related Content

Alzheimer’s Disease is the most common cause of dementia. Dementia describing a specific set of symptoms such as memory loss, difficulties with problem-solving, language or simply thinking. As the disease progresses, proteins build up in the brain to form structures called ‘plaques’. Eventually there is a break between the nerve cells resulting the death of the cells and a loss of brain tissue. ending in a lack of motor skills. Although progression can vary, typically after diagnosis life expectancy is around three to nine years. Fewer than 3% of people live more than fourteen years.

Management

Medications, psychological intervention and care-giving are all available to AD patients. there are currently 5 different medications on offer for AD each have different results and side affects.

insomnia in older person

Getting enough sleep is vital for healthy ageing

Dr Deborah Lee from Dr Fox Online Pharmacy analyses insomnia in the UK and why getting enough sleep is vital for healthy ageing.
Nurse holding patient's hand for dementia care

Overcoming global inequities in cognitive healthcare to combat dementia

CEO of ViewMind Inc, Mark Edwards, discusses overcoming global inequities in cognitive healthcare to combat the dementia epidemic.
images of a brain scan

Treatments for Alzheimer’s disease: understanding causes, diagnosis, prevention & cure

Abbas Kanani, Superintendent Pharmacist at Chemist Click Online Pharmacy, walks us through treatments for Alzheimer’s disease, researching the causes, diagnosis, prevention, and cure.
MRI Brain Scan of head and skull with hand pointing

Understanding amyloid beta and Alzheimer’s disease: the key to helping AD patients

Efforts to prevent or treat Alzheimer’s Disease (AD) by targeting Amyloid beta (Aβ) assemblies should be continued, but the strategies should be altered dramatically.
Cardiac amyloidosis is a condition where faulty proteins build up in your heart. You can inherit this condition, or it can develop on its own (usually later in life). As faulty proteins accumulate, your heart struggles to pump, ultimately leading to heart failure and death. amyloid

Understanding Amyloidosis, a group of rare diseases

In this interview, Abbas Kanani, MRPharmS, Superintendent Pharmacist at Chemist Click, tells us about amyloidosis, a group of rare diseases in which abnormal proteins deposit as amyloid in tissues and organs.
Alzheimer's disease detection sensor

Early Alzheimer’s disease detection sensor in development

Researchers are developing a new Alzheimer's disease detection sensor that can be used in the early stages of Alzheimers and a number of other diseases.

What is the optimal window for the early detection of Alzheimer’s disease?

Dr. Gerardo Fernandez, CSO ViewMind Inc, investigates how early is too early for the detection of Alzheimer’s disease and how soon in the disease’s trajectory detection can make a meaningful difference in a patient’s prognosis.
Root causes of amyloid-associated diseases

Why are the root causes of amyloid-associated diseases so misunderstood and treatments so inadequate?

The annual worldwide cost of treating amyloid-associated diseases is about a trillion dollars and increasing steadily. But the human toll is worse Amyloids are killing us, both literally and financially. Consider just these three: Amyloid β (Aβ) in Alzheimer’s Disease, α-Synuclein (α-Syn) in Parkinson’s Disease, and Amylin (aka IAPP) in...

New drug ‘Lecanemab’ slows the effects of Alzheimer’s disease

After decades of failure for Alzheimer’s researchers, Lecanemab could open the door to a new ear of drugs to treat Alzheimer’s disease – the world's most common form of dementia.
Brain disease diagnosis with medical doctor seeing Magnetic Resonance Imaging MRI film diagnosing elderly ageing patient neurodegenerative illness problem for neurological medical treatment

Machine learning is helping us understand Alzheimer’s disease

Using machine learning to pinpoint the most accurate means and timelines for anticipating the advancement of Alzheimer’s disease.
beer texture in a glass

Could beer hops give insight into treating Alzheimer’s?

Beer hops have been found to provide unique health benefits for Alzheimer’s disease, preventing the clumping of amyloid beta proteins.
brain scan image

COVID-19 causes brain inflammation similar to Parkinson’s disease

COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease – increasing the risk of future potential neurodegenerative conditions.
alzheimers, brain scan

The expansion of potential Alzheimer’s drugs

Alzheimers drugs have been shown able to target insulin receptors located in cerebral microvessels, massively expanding the future of drug production and testing

Unlocking life-changing dementia treatments

Is better diagnosis the key to unlocking life-changing dementia treatments? Dr Susan Mitchell, Head of Policy at Alzheimer’s Research UK provides the answer.
The epidemiology of Alzheimer’s - MRI brian of Dementia patient

PAVE: Global research study on epidemiology of Alzheimer’s disease

To improve understanding of the impact and epidemiology of Alzheimer’s disease, Project Alzheimer’s Value Europe (PAVE) demonstrates the prevalence of Alzheimer’s across the stages of the disease, including prodromal and preclinical – which aren’t recognised by previous studies.
Older women leaning over table and writing a letter as a leisure activity

Reduce risk of dementia through leisure activities

Dementia poses a risk to us all, but research shows that there are leisure activities that are scientifically proven to reduce risk of dementia.
ArrestAD

ArrestAD: Exploiting the bittersweet side of Alzheimer’s disease

The Alzheimer’s disease puzzle is being completed. This is where the ArrestAD programme comes in, to exploit the bittersweet side of AD.
Alzheimer’s, mild cognitive impairment

Digital biomarker predicts mild cognitive impairment conversion to Alzheimer’s

Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.

A Bluetooth tracking device to aid the search for older people with dementia who...

Getting lost can affect caregivers and families of older people with dementia – now, a Bluetooth tracking device can assist the search for their loved ones.
preclinical alzheimer's disease, novel marker

Searching for a novel marker of preclinical Alzheimer’s disease

Research suggests that multisensory integration could be used as a novel marker for preclinical Alzheimer’s disease given reported associations between magnitude of visual-somatosensory integration and important cognitive and motor outcomes.

Follow Open Access Government